Ozaraga, Renje O.

HRN: 26-26-10  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2024
CEFUROXIME 750MG (VIAL)
11/21/2024
11/28/2024
IV
750mg
Q8
Multiple Soft Tissue Injury Secondary To MVA
Waiting Final Action 
11/22/2024
MUPIROCIN 2%, 15G (TUBE)
11/22/2024
11/29/2024
TOPICAL
Apply Thinly
Bid
Multiple Soft Tissue Injury Secondary To MVA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: